FibroGen (FGEN) EV/EBITDA US GAAP (year values) |
|||||||||
| 2020 | 2021 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | -16.3 | -3.63 | -3.45 | -4.13 | -0.08 | 0.74 | ||
| Changes by years, y/y, % | -74% | -78% | -5% | +19% | -98% | -71.7% | |||
FibroGen. EV/EBITDA
FibroGen. EV/EBITDA, changes, %
FibroGen (FGEN) EV/EBITDA US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| EV/EBITDA | ? | 0.05 | -0.08 | -1.03 | -0.78 | 0.89 | 0.74 | |
| Changes by years, y/y, % | -102% | -98% | -79% | +187% | +1 799% | |||
| Changes by quarters, q/q, % | -117% | -279% | +1 129% | -25% | -215% | |||